The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients. Radiol Oncol [Internet]. 2016 Aug. 30 [cited 2026 Oct. 22];50(3). Available from: https://www.radioloncol.com/index.php/ro/article/view/2546